Scilex Holding Co (SCLX)
1.145
+0.04
(+3.15%)
USD |
NASDAQ |
May 22, 16:00
1.145
0.00 (0.00%)
After-Hours: 20:00
Scilex Cash from Investing (TTM): -0.48M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -0.48M |
December 31, 2023 | -0.33M |
September 30, 2023 | -0.163M |
Date | Value |
---|---|
June 30, 2023 | -0.015M |
March 31, 2023 | -2.067M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-2.067M
Minimum
Mar 2023
-0.015M
Maximum
Jun 2023
-0.611M
Average
-0.33M
Median
Dec 2023
Cash from Investing (TTM) Benchmarks
Sorrento Therapeutics Inc | -11.58M |
Adial Pharmaceuticals Inc | -- |
Precision BioSciences Inc | 6.524M |
Humacyte Inc | 0.588M |
Perspective Therapeutics Inc | -48.19M |